Pharmaceutical Compounding has been in the spotlight since a fungal meningitis outbreak has sickened more than 200 people and killed 15. But how does a lab end up with tainted products, like a fungus growing in a steroid compound?

Listen:

Amy Peak with the College of Pharmacy at Butler University says there was almost a perfect storm that caused the fungal meningitis outbreak.

Peak says a combination of a huge compounding pharmacy, a product that can't be produced with preservatives, along with an epidural that is injected into the spinal column, set the stage for a lot of people to get very ill.

Compounding Pharmacies are typically a lot smaller, according to Peak, who says operating at such a large scale, as the New England Compounding Center was, could easily lead to a large amount of tainted products that are distributed nationally.

MORE FROM WIBC NEWS:
» Second Death in Indiana from Fungal Meningitis Outbreak (10-13-12)
» Three More Meningitis Cases Confirmed in Indiana (10-12-12)
» Patient Injected in Indiana Becomes State's First Meningitis Death (10-11-12)
» Number of Fungal Meningitis Cases Climbs to 11 in Indiana (10-8-12)
» Fungal Meningitis Cases Jump In Indiana (10-7-12)
» Cases of Fungal Meningitis Climbs to Three in Indiana (10-5-12)
» Doctor Explains Fungal Meningitis (10-5-12)
» Rare Fungal Meningitis Spreads to Indiana (10-4-12)